Europe - EPA:EL - FR0000121667 - Common Stock
The current stock price of EL.PA is 318.35 EUR. In the past month the price increased by 14.95%. In the past year, price increased by 46.68%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ESL.DE | ESSILORLUXOTTICA | 46.48 | 147.88B | ||
| 1EL.MI | ESSILORLUXOTTICA | 46.26 | 147.19B | ||
| 2U3.DE | ALCON INC | 24.95 | 32.41B | ||
| 1ALC.MI | ALCON INC | 24.62 | 31.98B | ||
| CBHD.DE | COLOPLAST-B | 31.15 | 16.70B | ||
| AFW.DE | ALIGN TECHNOLOGY INC | 14.24 | 8.35B | ||
| GENT.OL | GENTIAN DIAGNOSTICS ASA | 20.59 | 854.27M | ||
| GBT.PA | GUERBET | 26.07 | 200.98M | ||
| ALCJ.PA | CROSSJECT | N/A | 125.35M | ||
| AFME.PA | AFFLUENT MEDICAL SA | N/A | 56.66M | ||
| SVS.MI | SVAS BIOSANA SPA | 7.35 | 52.30M | ||
| PTP.DE | PENTIXAPHARM HOLDING AG | N/A | 37.20M |
EssilorLuxottica SA engages in the design, manufacture, and distribution of ophthalmic lenses, frames and sunglasses. The company is headquartered in Paris, Ile-De-France and currently employs 200,076 full-time employees. The firm designs, distributes, manufactures, and markets a range of lenses, frames, and sunglasses to improve and protect eyesight. The company also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals. The company operates through three segments: Lenses and Optical Instruments, which includes corrective lenses, optical instruments intended for opticians and optometrists; Equipment, which includes machines and consumables used by plants and prescription laboratories, and Sunglasses & Readers, which encompasses non-prescription reading glasses and non-prescription sunglasses. EssilorLuxottica's assets include recognized brands, such as Ray-Ban and Oakley for eyewear, Varilux and Transitions for ophthalmic optical technologies, and Sunglass Hut and Lenscrafters for international distribution networks.
ESSILORLUXOTTICA
1-6 rue Paul Cezanne
Paris ILE-DE-FRANCE FR
Employees: 153498
Phone: 33149774224
EssilorLuxottica SA engages in the design, manufacture, and distribution of ophthalmic lenses, frames and sunglasses. The company is headquartered in Paris, Ile-De-France and currently employs 200,076 full-time employees. The firm designs, distributes, manufactures, and markets a range of lenses, frames, and sunglasses to improve and protect eyesight. The company also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals. The company operates through three segments: Lenses and Optical Instruments, which includes corrective lenses, optical instruments intended for opticians and optometrists; Equipment, which includes machines and consumables used by plants and prescription laboratories, and Sunglasses & Readers, which encompasses non-prescription reading glasses and non-prescription sunglasses. EssilorLuxottica's assets include recognized brands, such as Ray-Ban and Oakley for eyewear, Varilux and Transitions for ophthalmic optical technologies, and Sunglass Hut and Lenscrafters for international distribution networks.
The current stock price of EL.PA is 318.35 EUR. The price increased by 0.02% in the last trading session.
ESSILORLUXOTTICA (EL.PA) has a dividend yield of 1.27%. The yearly dividend amount is currently 2.56.
EL.PA has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
EL.PA stock is listed on the Euronext Paris - Matif exchange.
The PE ratio for ESSILORLUXOTTICA (EL.PA) is 46.34. This is based on the reported non-GAAP earnings per share of 6.87 and the current share price of 318.35 EUR.
ESSILORLUXOTTICA (EL.PA) will report earnings on 2026-02-03, after the market close.
ChartMill assigns a technical rating of 10 / 10 to EL.PA. When comparing the yearly performance of all stocks, EL.PA is one of the better performing stocks in the market, outperforming 91.65% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to EL.PA. EL.PA has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months EL.PA reported a non-GAAP Earnings per Share(EPS) of 6.87. The EPS increased by 3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.74% | ||
| ROA | 3.84% | ||
| ROE | 6.29% | ||
| Debt/Equity | 0.25 |
30 analysts have analysed EL.PA and the average price target is 290.43 EUR. This implies a price decrease of -8.77% is expected in the next year compared to the current price of 318.35.
For the next year, analysts expect an EPS growth of 6.78% and a revenue growth 4.62% for EL.PA